Abstract
Albumin plays a critical role in extracorporeal therapies and artificial organ systems, serving as both a therapeutic molecule and a functional component in device performance. This symposium, titled *Innovative Approaches in Albumin-Based Therapies: From Research to Clinical Applications in Artificial Organs*, will explore the latest advancements in this dynamic field, bridging cutting-edge research with clinical practice.
The session will begin with a keynote lecture by Prof. Steffen Mitzner (Germany, Rostock), who will provide a comprehensive overview of albumin’s role in artificial organ technologies, addressing its mechanisms, clinical potential, and future directions. Subsequent talks will delve into specific aspects of albumin-based therapies, including its application in renal and liver support devices (Tobias Bingold, ADVITOS, and Jan Stange, Albutec). The symposium will conclude with insights into albumin’s immunomodulatory properties and its ability to reduce inflammation in extracorporeal circuits (Kristina Boss, Sophie Brabandt).
By integrating fundamental research with real-world clinical applications, this symposium will highlight how albumin-based innovations are transforming the landscape of artificial organ technologies, offering new opportunities to enhance patient outcomes and address critical care challenges.
Chairs
- Gerd Klinkmann MD, PhD (Rostock)
- Kristina Boss MD, PhD (Essen)
The programme
Time | Presentation |
|---|---|
Welcome & introduction | |
30 min | Keynote talkThe Role of Albumin in Artificial Organ Technologies: Insights and Future PerspectivesProf. Dr.med. Steffen Mitzner |
15 min | Nxecad Reduces Clif Expected 6 Months Mortality In Aclf Superior To Mars In Line With Significant Improvement Of Albumin Binding FunctionJan Stange MD, PhD, Albutec GmbH |
15 min | Extracorporeal Multiorgan Support Efectively Corrects Acidosis And Improves The Standardized Mortality Ratio: Analysis Of Patients With Acidosis From The Emos-RegistryTobias Bingold MD, PhD, ADVITOS GmbH |
15 min | 1-Year-Follow-Up: Alterations Of Albumin Function After Kidney TransplantationKristina Boss, Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Germany |
15 min | Online Monitoring Of The Effectiveness And Capacity Of Albumin Dialysis Procedures For Extracorporeal Liver Replacement TherapySebastian Koball, MD, University of Rostock, Internal Medicine, Nephrology and Dialysis, Germany |
| Closing words |